foxo4-dri senolytic mouse 2023 2024 FOX04-DRI FOXO4-DRI: Human Trial Status, Cancer
FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Molecule kills elderly cells, reduces signs of aging in mice Science AAAS Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Immunofluorescence reveals the effect of FOXO4 D Retro Inverso on p53 Download Scientific Diagram
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




